Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra

Journal of Biomolecular NMR

Volumn 49, Issue 3-4, 2011, Pages 307-323

  Mercier, Pascal ^a   Lewis, Michael J ^a   Chang, David ^a,d   Baker, David ^c   Wishart, David S ^b  

^a Chenomx Inc   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c PFIZER INC   (United States)

^d Products and Services   (Canada)

Author keywords

Automated targeted spectral profiling; Metabolomics; Nuclear magnetic resonance; Targeted profiling

Indexed keywords

ALGORITHM; ARTICLE; AUTOMATION; DATA ANALYSIS; HUMAN; MASS SPECTROMETRY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ALGORITHMS; AUTOMATION; BODY FLUIDS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; PROTONS;

EID: 79958766718     PISSN: 09252738     EISSN: 15735001     Source Type: Journal    
DOI: 10.1007/s10858-011-9480-x     Document Type: Article

References (59)

1. Aich P, Potter AA, Griebel PJ (2009) Modern approaches to understanding stress and disease susceptibility: a review with special emphasis on respiratory disease. Int J Gen Med 2:19-32
2. Altman DG, Bland JM (1994) Diagnostic tests 1: sensitivity and specificity. BMJ 308:1552 (Pubitemid 24178459)
3. Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TM, Holmes E, Lindon JC, Nicholson JK (2010) High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc 5:1019-1032
4. Bertram HC, Eggers N, Eller N (2009) Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Anal Chem 81:9188-9193
5. Bezabeh T, Somorjai RL, Smith ICP (2009) MR metabolomics of fecal extracts: applications in the study of bowel diseases. Magn Reson Chem 47:S54-S61
6. Cevallos-Cevallos JM, Reyes-De-Corcuera JI, Etxeberria E, Danyluk MD, Rodrick GE (2009) Metabolomic analysis in food science: a review. Trends Food Sci Tech 20:557-566
7. Chang D, Banack CD, Shah SL (2007a) Robust baseline correction algorithm for signal dense NMR spectra. J Magn Reson 187:288-292 (Pubitemid 47069018)
8. Chang D, Weljie A, Newton J (2007b) Leveraging latent information in NMR spectra for robust predictive models. Pac Symp Biocomput 115-126
9. Chen C, Gonzalez FJ, Idle JR (2007a) LC-MS-based metabolomics in drug metabolism. Drug Metab Rev 39:581-597 (Pubitemid 47355739)
10. Chen DJ, Lee CY, Park CH, Mendes P (2007b) Parallelizing simulated annealing algorithms based on high-performance computer. J Global Optim 39:261-289
11. Chenomx Nmr Suite (2010) Chenomx Inc., Edmonton, AB, Canada. http://www.chenomx.com
12. Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, Westler WM, Eghbalnia HR, Sussman MR, Markley JL (2008) Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol 26:162-164
13. Fonville JM, Maher AD, Coen M, Holmes E, Lindon JC, Nicholson JK (2010) Evaluation of full-resolution J-resolved 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification. Anal Chem 82:1811-1821
14. Frassineti C, Ghelli S, Gans P, Sabatini A, Moruzzi MS, Vacca A (1995) Nuclear magnetic resonance as a tool for determining protonation constants of natural polyprotic bases in solution. Anal Biochem 231:374-382
15. Griffin JL, Kauppinen RA (2007) Tumour metabolomics in animal models of human cancer. J Proteome Res 6:498-505 (Pubitemid 46340153)
16. Hall RD, Brouwer ID, Fitzgerald MA (2008) Plant metabolomics and its potential application for human nutrition. Physiol Plant 132:162-175
17. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48:653-683 (Pubitemid 351738167)
18. Keun HC (2006) Metabonomic modeling of drug toxicity. Pharmacol Ther 109:92-106
19. Kim YS, Maruvada P, Milner JA (2008) Metabolomics in biomarker discovery: future uses for cancer prevention. Futur Oncol 4:93-102 (Pubitemid 351372610)
20. Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, Thompson IM, Weiss RH (2009) Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8:558-570
21. Kimura T, Noguchi Y, Shikata N, Takahashi M (2009) Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks. Curr Opin Clin Nutr Metab Care 12:49-53
22. Kristal BS, Shurubor Y, Marur V (2007) Projection-based informatics approaches to serum/plasma metabolomics data: applications to biomarkers for caloric intake in rats. Faseb J 21:A310-A310
23. Li H, Jiang Y, He FC (2008) Recent development of metabonomics and its applications in clinical research. Yi Chuan 30:389-399
24. Lindon JC, Nicholson JK (2008) Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem 1:45-69
25. Lindon JC, Nicholson JK, Holmes E (2007) The handbook of metabonomics and metabolomics, 1st edn. Elsevier, Amsterdam
26. Markley JL, Anderson ME, Cui Q, Eghbalnia HR, Lewis IA, Hegeman AD, Li J, Schulte CF, Sussman MR, Westler WM, Ulrich EL, Zolnai Z (2007) New bioinformatics resources for metabolomics. Pac Symp Biocomput 157-168
27. Milgram E, Nordstrom A (2009) Asms metabolomics workshop survey. http://fiehnlab.ucdavis.edu/staff/kind/Metabolomics-Survey-2009/
28. Moore JG, Sillerud OL (1994) The pH dependence of chemical shift and spin-spin coupling for citrate. J Magn Res B 103:87-88
29. Morris GA, Barjat H, Home TJ (1997) Reference deconvolution methods. Prog Nucl Mag Res Sp 31:197-257 (Pubitemid 127427695)
30. Oakman C, Tenori L, Biganzoli L, Santarpia L, Cappadona S, Luchinat C, Di Leo A (2010) Uncovering the metabolomic fingerprint of breast cancer. Int J Biochem Cell Biol
31. Odunsi K (2007) Cancer diagnostics using 1H-NMR-based metabonomics. Ernst Schering Found Symp Proc 4:205-226
32. Poullet JB, Sima DM, Simonetti AW, De Neuter B, Vanhamme L, Lemmerling P, Van Huffel S (2007) An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES. NMR Biomed 20:493-504 (Pubitemid 47272369)
33. Poullet JB, Sima DM, Van Huffel S (2008) MRS signal quantitation: a review of time- and frequency-domain methods. J Magn Reson 195:134-144
34. Quinones MP, Kaddurah-Daouk R (2009) Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 35:165-176
35. Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S (2009) Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 5:435-458
36. Schiffmann R, Waldek S, Benigni A, Auray-Blais C (2010) Biomarkers of Fabry disease nephropathy. Clin J Am Soc Nephrol 5:360-364
37. Serkova NJ, Niemann CU (2006) Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev Mol Diagn 6:717-731 (Pubitemid 44525597)
38. Sima DM, Van Huffel S (2006) Regularized semiparametric model identification with application to nuclear magnetic resonance signal quantification with unknown macromolecular base-line. J Roy Stat Soc B 68:383-409 (Pubitemid 43742900)
39. Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PM, Rauz S, Young SP (2010) NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - a diagnostic tool? NMR Biomed 23:123-132
40. Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15:431-440
41. Staab JM, O'Connell TM, Gomez SM (2010) Enhancing metabolomic data analysis with Progressive Consensus Alignment of NMR Spectra (PCANS). BMC Bioinform 11:123
42. Stein SE, Scott DR (1994) Optimization and testing of mass-spectral library search algorithms for compoud identification. J Am Soc Mass Spectr 5:859-866
43. Tainsky MA (2009) Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta 1796:176-193
44. Tiziani S, Lopes V, Gunther UL (2009) Early stage diagnosis of oral cancer using 1HNMR-based metabolomics.Neoplasia 11:269-276
45. Van Der Graaf M, Heerschap A (1996) Effect of cation binding on the proton chemical shifts and the spin-spin coupling constant of citrate. J Magn Res B 112:58-62 (Pubitemid 126758703)
46. Vangala S, Tonelli A (2007) Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity? AAPS J 9:E284-E297
47. Veselkov KA, Lindon JC, Ebbels TMD, Crockford D, Volynkin VV, Holmes E, Davies DB, Nicholson JK (2009) Recursive segment-wise peak alignment of biological 1H NMR spectra for improved metabolic biomarker recovery. Anal Chem 81:56-66
48. Waterman CL, Kian-Kai C, Griffin JL (2010) Metabolomic strategies to study lipotoxicity in cardiovascular disease. Biochim Biophys Acta 1801:230-234
49. Weiss RH, Kim K, Tolstikov V (2008) Use of urinary metabolomics to identify biomarkers for kidney cancer. Cancer Biomark 4:167-167
50. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM (2006) Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78:4430-4442
51. Wishart DS (2008a) Applications of metabolomics in drug discovery and development. Drugs R&d 9:307-322
52. Wishart DS (2008b) Metabolomics: applications to food science and nutrition research. Trends Food Sci Tech 19:482-493
53. Wishart DS (2008c) Quantitative metabolomics using NMR. Tractrend Anal Chem 27:228-237
54. Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L (2008) The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci 871:164-173
55. Wolfender JL, Glauser G, Boccard J, Rudaz S (2009) MS-based plant metabolomic approaches for biomarker discovery. Nat Prod Commun 4:1417-1430
56. Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC (2009) Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers. Clin Chim Acta 400:63-69
57. Xi Y, Rocke DM (2008) Baseline correction for NMR spectroscopic metabolomics data analysis. BMC Bioinform 9:324
58. Xia JG, Bjorndahl TC, Tang P, Wishart DS (2008) MetaboMiner - semi-automated identification of metabolites from 2D NMR spectra of complex biofluids. Bmc Bioinform 9:ARTN 507
59. Young SP, Wallace GR (2009) Metabolomic analysis of human disease and its application to the eye. J Ocul Biol Dis Infor 2:235-242